Profile
BCAX VRTX REGN SGEN ARGX ALNY
Company Name Bicara Therapeutics Inc. Common Stock Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $648.44M $128.84B $64.28B $43.15B $39.39B $33.74B
Employees 0.06K 6.10K 15.16K 3.26K 1.60K 2.23K
CEO Ms. Claire Mazumdar Clemon M.B.A., Ph.D. Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc. Dr. Yvonne L. Greenstreet M.B.A., M.D.
Ratings
BCAX VRTX REGN SGEN ARGX ALNY
Quant Rating Score 2 2 4 3 3 1
Quant Rating Sell Sell Buy Neutral Neutral Strong Sell
Trading
BCAX VRTX REGN SGEN ARGX ALNY
Last Close $11.89 $434.82 $560.93 $228.74 $622.93 $276.55
High 52 $26.64 $516.74 $1201.76 $228.74 $671.75 $296.75
Low 52 $9.37 $396.64 $546.39 $228.74 $356.01 $146.93
Price vs. 52 Week High -55.37 % -15.85 % -53.32 % 0 % -7.27 % -6.81 %
Price vs. 52 Week Low 26.89 % 9.63 % 2.66 % 0 % 74.98 % 88.22 %
Total Return
BCAX VRTX REGN SGEN ARGX ALNY
1 Month Return 26.89 % -7.95 % 0.65 % 0 % 13.57 % 23.14 %
3 Month Return -1.98 % -7.35 % -20.94 % 0 % -3.67 % 0.13 %
6 Month Return -50.28 % -15.85 % -32.29 % 0 % 4.52 % -0.32 %
9 Month Return 0 % -6.68 % -49.62 % 0 % 18.6 % 2.25 %
YTD Return -31.75 % 7.98 % -21.25 % 0 % 1.29 % 17.53 %
1 Year Return 0 % 3.82 % -41.31 % 0 % 61.35 % 81.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BCAX VRTX REGN SGEN ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.15 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -1052.83 % -1.65 % 3.85 % -2.27 % -44.32 % -1.49 %
Dividend Per Share (TTM) - - 0.88 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Growth
BCAX VRTX REGN SGEN ARGX ALNY
Asset Growth 117.96 % -0.87 % -1.21 %
Gross Profit Growth - 10.25 % 22.93 %
Revenue Growth - 11.66 % 24.65 %
Revenue 3 Year - 45.6 % 91.56 %
Revenue 5 Year - 163.93 % 215.48 %
Revenue 10 Year - 1632.15 % 494.04 %
EBIT Growth -30.45 % -93.69 % 10.13 %
Net Income Growth -30.8 % -114.8 % 9.51 %
Net Income 3 Yeari Growth Per Share 44.66 % -122.89 % -763.59 %
Net Income 5 Yeari Growth Per Share 44.66 % -145.38 % -276.93 %
Net Income 10 Yeari Growth Per Share 44.66 % 33.84 % -624.16 %
Operating Income Growth -106.55 % -105.41 % 10.13 %
Operating Cash Flow Growth (CFG) -63.83 % -113.93 % 9.07 %
Operating 3 Year CFG 28.22 % -118.65 % -147.99 %
Operating 5 Year CFG 28.22 % -131.3 % -195.86 %
Operating 10 Year CFG 28.22 % 12.43 % -2622.09 %
EPS Growth 60 % -114.8 % 10.81 %
EPS Diluted Growth 60 % -114.97 % 10.81 %
Book Value Per Share 201.83 % -6.59 % -9.83 %
Share Holder 3 Year Equity Growth Per Share 253.33 % 62.6 % 33.72 %
Share Holder 5 Year Equity Growth Per Share 253.33 % 168.85 % 220.81 %
Share Holder 10 Year Equity Growth Per Share 253.33 % 1265.7 % 691.19 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth 12.33 % 116.42 % -23.28 %
Free Cash Flow Growth -61.9 % -124.1 % 3.67 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2022
Profitability
BCAX VRTX REGN SGEN ARGX ALNY
Gross Profit Margin TTM - 86.09 % 84.94 % 72.37 % 46.33 % 86.01 %
Return on Assets TTM -13.33 % -2.38 % 11.98 % -11.76 % 13.45 % -6.4 %
Return on Equity TTM -26.69 % -3.28 % 14.77 % -16.53 % 16.83 % -509.33 %
Return on Capital Employed TTM -16.75 % -1.3 % 11.35 % -16.87 % -0.31 % -3.68 %
Net Income Per EBT TTM 100.28 % -215.53 % 90.27 % 100.55 % 25990.14 % 75.89 %
EBT Per Ebit TTM 82.3 % -100.69 % 129.3 % 94.01 % -18.79 % 308.03 %
EBIT Per Revenue TTM - -2.24 % 27.37 % -36.09 % -0.77 % -4.91 %
Cash Flow To Debt Ratio TTM -10128.86 % -28.16 % 146.15 % -185.98 % -201.37 % -3.47 %
Receivables Turnover TTM - 6.84 2.53 1.98 2.46 5.62
Payables Turnover TTM - 3.71 3.01 1.54 1.83 3.37
Inventory Turnover TTM - 1.27 0.66 0.65 2.93 5.01
Fixed Asset Turnover TTM - 425.82 % 300.07 % 256.83 % 5106.8 % 337.41 %
Asset Turnover TTM - 48.84 % 37.52 % 34.46 % 35.83 % 55.72 %
Operating Cash Flow Per Share TTM -1.37 -1.91 37.05 -1.12 -1.07 -0.35
Free Cash Flow Per Share TTM -1.37 -3.07 28.3 -1.62 -1.09 -0.58
Cash Per Share TTM 899.54 % 2375.11 % 7825.12 % 657.5 % 4597.04 % 2024.29 %
Operating Cash Flow Sales Ratio TTM - -4.48 % 28.06 % -16.85 % -3.54 % -1.92 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.09 % 160.43 % 76.4 % 144.14 % 102.26 % 167.11 %
Cash Flow Coverage Ratios TTM -10128.86 % -28.16 % 146.15 % -185.98 % -201.37 % -3.47 %
Price To Free Cash Flows Ratio TTM -8.67 -163.02 21.29 -141.85 -505.86 -447.57
Price To Operating Cash Flows Ratio TTM -8.66 -261.97 16.35 -203.89 -601.06 -745.64
Price Cash Flow Ratio TTM -8.66 -261.97 16.35 -203.89 -601.06 -745.64
Income Statement (TTM)
BCAX VRTX REGN SGEN ARGX ALNY
Revenue $0B $11.02B $14.2B $1.96B $2.19B $2.25B
Gross Profit $0B $9.49B $12.23B $1.55B $1.96B $1.92B
Gross Profit Ratio 0% 86.11% 86.13% 79.1% 89.62% 85.62%
EBITDA $-0.07B $0.48B $5.32B $-0.62B $0B $-0.18B
Net Income $-0.07B $-0.54B $4.41B $-0.61B $0.83B $-0.28B
EPS Diluted -0.4 -2.08 38.34 -3.3 12.78 -2.16
Balance Sheet (MRQ)
BCAX VRTX REGN SGEN ARGX ALNY
Long Term Debt $0B $1.66B $1.98B $0.04B $0.03B $0B
Total Liabilities $0.02B $6.12B $8.41B $0.87B $0.7B $4.17B
Total Equity $0.49B $16.41B $29.35B $2.8B $5.5B $0.07B
Total Investments $0B $6.65B $15.42B $1.42B $1.93B $1.73B
Total Debt $0B $1.75B $2.7B $0.04B $0.04B $1.3B
Total Assets $0.51B $22.53B $37.76B $3.67B $6.2B $4.3B
Cash Flow Statement (TTM)
BCAX VRTX REGN SGEN ARGX ALNY
Net Income $-0.07B $-0.54B $4.41B $-0.61B $0.8B $-0.28B
Inventory $0B $-0.52B $-0.62B $-0.23B $-0.09B $0.01B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.07B $-0.49B $4.42B $-0.45B $-0.08B $-0.01B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.08B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 25.16
ABCL AbCellera Biologics Inc. 2.005
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.48
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1
ABPWW 0.02
ABSI Absci Corporation 2.79
ABUS Arbutus Biopharma Corporation 3.295
ABVC ABVC BioPharma, Inc. 1.31
ABVX Abivax SA American Depositary Shares 6.87
ACAD ACADIA Pharmaceuticals Inc. 16.95
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.4785
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.44
ACIU AC Immune SA 1.645
ACLX Arcellx, Inc. 56.08
ETFs With Exposure to BCAX
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.01229 201.195
VTI Vanguard Total Stock Market Index Fund 0 278.14
SCHB Schwab U.S. Broad Market ETF 0.00040231 21.785
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00116 123.45
SCHA Schwab U.S. Small-Cap ETF 0.0068364 23.685
IWN iShares Russell 2000 Value ETF 0.0105 149.16
IWV iShares Russell 3000 ETF 0.00096 321.525
IWO iShares Russell 2000 Growth ETF 0.01309 262.535
VXF Vanguard Extended Market Index Fund 0 177.365
HDG ProShares Hedge Replication ETF 0.00138385 48.6643
UWM ProShares Ultra Russell2000 0.00358699 33.035
VTHR Vanguard Russell 3000 Index Fund 0 249.575
ONEQ Fidelity Nasdaq Composite Index ETF 0 70.68
URTY ProShares UltraPro Russell2000 0.00206936 32.66
VTWV Vanguard Russell 2000 Value Index Fund 0.01 131.47
ISCB iShares Morningstar Small-Cap ETF 0.00948 54.71
VTWG Vanguard Russell 2000 Growth Index Fund 0.01 191.975
VTWO Vanguard Russell 2000 Index Fund 0.01 81.3
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 93.91
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 93.89
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 46.89
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 46.88
VBINX Vanguard Balanced Index Fund Investor Shares 0 46.88
VTSAX Vanguard Total Stock Market Index Fund 0 134.42
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 132.11
VITSX Vanguard Total Stock Market Index Fund 0 134.44
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 132.12
BBSC JPMorgan BetaBuilders U.S. Small Cap Equity ETF 0.03 61.185
TMSL T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Small-Mid Cap ETF 0.0492625 30.825
VEMPX Vanguard Extended Market Index InstlPlus 0 326.02
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 252.2
RSSL Global X Funds 0.01 79.05
Unlock